Low Dose Extended-release Epidural and Lumbar Plexus Block Compared to Lumbar Plexus Block for Total Hip Resurfacing
Low Dose Extended-release Epidural Morphine in Conjunction With Lumbar Plexus Block Versus Lumbar Plexus Block Alone for Total Hip Resurfacing Arthroplasty: A Randomized Controlled Trial.
Sponsor: EKR Therapeutics, Inc
Terminated
Drug was discontinued by manufacturer
Other terminated trials from EKR Therapeutics, Inc
More terminations from EKR Therapeutics, Inc
Other Hip Arthroplasty trials with similar outcome
Listed as NCT00934661, this PHASE4 trial focuses on Hip Arthroplasty and remains terminated or withdrawn. Sponsored by EKR Therapeutics, Inc, it has been updated 8 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Oct 2018 — Jan 2021 [monthly]
Terminated PHASE4
-
Jun 2018 — Oct 2018 [monthly]
Terminated PHASE4
▶ Show 3 earlier versions
-
Feb 2018 — Jun 2018 [monthly]
Terminated PHASE4
Status: Unknown Status → Terminated · Phase: NA → PHASE4
-
Feb 2017 — Feb 2018 [monthly]
Unknown Status NA
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status NA
First recorded
Jan 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- EKR Therapeutics, Inc
- Wake Forest University
For direct contact, visit the study record on ClinicalTrials.gov .